Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Isocitrate dehydrogenase (IDH) (EC 1.1.1.42) and (EC 1.1.1.41) is an enzyme that catalyzes the oxidative decarboxylation of isocitrate, producing alpha-ketoglutarate (?-ketoglutarate) and CO2.
The report details the trend, potential and market size of Isocitrate Dehydrogenase Inhibitors market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Isocitrate Dehydrogenase Inhibitorsmarket, defines the market attractiveness level of Isocitrate Dehydrogenase Inhibitors market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Isocitrate Dehydrogenase Inhibitors industry, describes the types of Isocitrate Dehydrogenase Inhibitors market, the applications of major players and the market size, and deeply analyzes the current situation of the global Isocitrate Dehydrogenase Inhibitors market and the development prospects and opportunities of Isocitrate Dehydrogenase Inhibitors industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Isocitrate Dehydrogenase Inhibitors market in Chapter 13.
By Player:
Celgene
Tragara/Adastra
Bristol-Myers Squibb
Beigene
Bayer
Tocagen
AGIOS
Daiichi Sankyo
Tesaro
Aslan Pharmaceuticals
By Type:
IDH1 Mutant Medullary Malignant Tumor
IDH2 Mutant Medullary Malignant Tumor
Others
By End-User:
DH Inhibitor
FLT3 Inhibitor
Hedgehog Pathway Inhibitor
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Isocitrate Dehydrogenase Inhibitors Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Isocitrate Dehydrogenase Inhibitors Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Isocitrate Dehydrogenase Inhibitors Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Isocitrate Dehydrogenase Inhibitors Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Isocitrate Dehydrogenase Inhibitors Market Analysis and Outlook to 2022
-
7.1 Global Isocitrate Dehydrogenase Inhibitors Consumption (2017-2022)
-
7.2 United States Isocitrate Dehydrogenase Inhibitors Consumption (2017-2022)
-
7.3 Europe Isocitrate Dehydrogenase Inhibitors Consumption (2017-2022)
-
7.4 China Isocitrate Dehydrogenase Inhibitors Consumption (2017-2022)
-
7.5 Japan Isocitrate Dehydrogenase Inhibitors Consumption (2017-2022)
-
7.6 India Isocitrate Dehydrogenase Inhibitors Consumption (2017-2022)
-
7.7 South Korea Isocitrate Dehydrogenase Inhibitors Consumption (2017-2022)
8 Region and Country-wise Isocitrate Dehydrogenase Inhibitors Market Analysis and Outlook to 2028
-
8.1 Global Isocitrate Dehydrogenase Inhibitors Consumption Forecast (2022-2028)
-
8.2 United States Isocitrate Dehydrogenase Inhibitors Consumption Forecast (2022-2028)
-
8.3 Europe Isocitrate Dehydrogenase Inhibitors Consumption Forecast (2022-2028)
-
8.4 China Isocitrate Dehydrogenase Inhibitors Consumption Forecast (2022-2028)
-
8.5 Japan Isocitrate Dehydrogenase Inhibitors Consumption Forecast (2022-2028)
-
8.6 India Isocitrate Dehydrogenase Inhibitors Consumption Forecast (2022-2028)
-
8.7 South Korea Isocitrate Dehydrogenase Inhibitors Consumption Forecast (2022-2028)
9 Global Isocitrate Dehydrogenase Inhibitors Market Outlook by Types and Applications to 2022
-
9.1 Global Isocitrate Dehydrogenase Inhibitors Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global IDH1 Mutant Medullary Malignant Tumor Consumption and Growth Rate (2017-2022)
-
9.1.2 Global IDH2 Mutant Medullary Malignant Tumor Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Isocitrate Dehydrogenase Inhibitors Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global DH Inhibitor Consumption and Growth Rate (2017-2022)
-
9.2.2 Global FLT3 Inhibitor Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Hedgehog Pathway Inhibitor Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Isocitrate Dehydrogenase Inhibitors Market Outlook by Types and Applications to 2028
-
10.1 Global Isocitrate Dehydrogenase Inhibitors Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global IDH1 Mutant Medullary Malignant Tumor Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global IDH2 Mutant Medullary Malignant Tumor Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Isocitrate Dehydrogenase Inhibitors Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global DH Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global FLT3 Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Hedgehog Pathway Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Isocitrate Dehydrogenase Inhibitors Import and Export Analysis (Top 5 Countries)
-
11.1 Global Isocitrate Dehydrogenase Inhibitors Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Isocitrate Dehydrogenase Inhibitors Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Isocitrate Dehydrogenase Inhibitors Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Isocitrate Dehydrogenase Inhibitors Market Competitive Analysis
-
14.1 Celgene
-
14.1.1 Celgene Company Details
-
14.1.2 Celgene Isocitrate Dehydrogenase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Celgene Isocitrate Dehydrogenase Inhibitors Product and Service
-
14.2 Tragara/Adastra
-
14.2.1 Tragara/Adastra Company Details
-
14.2.2 Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Product and Service
-
14.3 Bristol-Myers Squibb
-
14.3.1 Bristol-Myers Squibb Company Details
-
14.3.2 Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Product and Service
-
14.4 Beigene
-
14.4.1 Beigene Company Details
-
14.4.2 Beigene Isocitrate Dehydrogenase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Beigene Isocitrate Dehydrogenase Inhibitors Product and Service
-
14.5 Bayer
-
14.5.1 Bayer Company Details
-
14.5.2 Bayer Isocitrate Dehydrogenase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Bayer Isocitrate Dehydrogenase Inhibitors Product and Service
-
14.6 Tocagen
-
14.6.1 Tocagen Company Details
-
14.6.2 Tocagen Isocitrate Dehydrogenase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Tocagen Isocitrate Dehydrogenase Inhibitors Product and Service
-
14.7 AGIOS
-
14.7.1 AGIOS Company Details
-
14.7.2 AGIOS Isocitrate Dehydrogenase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 AGIOS Isocitrate Dehydrogenase Inhibitors Product and Service
-
14.8 Daiichi Sankyo
-
14.8.1 Daiichi Sankyo Company Details
-
14.8.2 Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Product and Service
-
14.9 Tesaro
-
14.9.1 Tesaro Company Details
-
14.9.2 Tesaro Isocitrate Dehydrogenase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Tesaro Isocitrate Dehydrogenase Inhibitors Product and Service
-
14.10 Aslan Pharmaceuticals
-
14.10.1 Aslan Pharmaceuticals Company Details
-
14.10.2 Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Isocitrate Dehydrogenase Inhibitors
-
Figure Isocitrate Dehydrogenase Inhibitors Picture
-
Table Global Isocitrate Dehydrogenase Inhibitors Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Isocitrate Dehydrogenase Inhibitors Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Isocitrate Dehydrogenase Inhibitors Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Isocitrate Dehydrogenase Inhibitors Consumption by Country (2017-2022)
-
Figure United States Isocitrate Dehydrogenase Inhibitors Consumption and Growth Rate (2017-2022)
-
Table Europe Isocitrate Dehydrogenase Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure China Isocitrate Dehydrogenase Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Japan Isocitrate Dehydrogenase Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure India Isocitrate Dehydrogenase Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure South Korea Isocitrate Dehydrogenase Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Isocitrate Dehydrogenase Inhibitors Consumption Forecast by Country (2022-2028)
-
Figure United States Isocitrate Dehydrogenase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Isocitrate Dehydrogenase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Isocitrate Dehydrogenase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Isocitrate Dehydrogenase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Isocitrate Dehydrogenase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Isocitrate Dehydrogenase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global IDH1 Mutant Medullary Malignant Tumor Consumption and Growth Rate (2017-2022)
-
Figure Global IDH2 Mutant Medullary Malignant Tumor Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global DH Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure Global FLT3 Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure Global Hedgehog Pathway Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global IDH1 Mutant Medullary Malignant Tumor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global IDH2 Mutant Medullary Malignant Tumor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global DH Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global FLT3 Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hedgehog Pathway Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Isocitrate Dehydrogenase Inhibitors Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Isocitrate Dehydrogenase Inhibitors Export by Region (Top 5 Countries) (2017-2028)
-
Table Celgene (Foundation Year, Company Profile and etc.)
-
Table Celgene Isocitrate Dehydrogenase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Isocitrate Dehydrogenase Inhibitors Product and Service
-
Table Tragara/Adastra (Foundation Year, Company Profile and etc.)
-
Table Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Product and Service
-
Table Beigene (Foundation Year, Company Profile and etc.)
-
Table Beigene Isocitrate Dehydrogenase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Beigene Isocitrate Dehydrogenase Inhibitors Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Isocitrate Dehydrogenase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Isocitrate Dehydrogenase Inhibitors Product and Service
-
Table Tocagen (Foundation Year, Company Profile and etc.)
-
Table Tocagen Isocitrate Dehydrogenase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tocagen Isocitrate Dehydrogenase Inhibitors Product and Service
-
Table AGIOS (Foundation Year, Company Profile and etc.)
-
Table AGIOS Isocitrate Dehydrogenase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table AGIOS Isocitrate Dehydrogenase Inhibitors Product and Service
-
Table Daiichi Sankyo (Foundation Year, Company Profile and etc.)
-
Table Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Product and Service
-
Table Tesaro (Foundation Year, Company Profile and etc.)
-
Table Tesaro Isocitrate Dehydrogenase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tesaro Isocitrate Dehydrogenase Inhibitors Product and Service
-
Table Aslan Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Product and Service
-
